Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEASEIN: Biomarkers of Resistance in Locally Advanced Breast Cancer
NCT03255486Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Jul 2013
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in breast cancer, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Predictive molecular abnormalities assessment at 5 years. Started Jul 2013; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03255486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03255486.